Search results
Results from the WOW.Com Content Network
Here is whether Pfizer stock might be a buy today -- and why. Pfizer's pandemic boom (and bust) shouldn't haunt the stock much longer. Dividend investors will focus on Pfizer's current dividend ...
Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...
*Stock prices used were the afternoon prices of Dec. 31, 2024. The video was published on Jan. 2, 2024. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this:
PFE Revenue (TTM) data by YCharts Pfizer's vaccine (Comirnaty) and treatment option (Paxlovid) combined for $56 billion in revenue in 2022. Those two products represented just $2.4 billion of ...
Drugs developed by Wyeth (31 P) Pages in category "Drugs developed by Pfizer" The following 200 pages are in this category, out of approximately 240 total.
The median increase—which is only to the list price and does not include rebates or other discounts—is similar year over year at 4.5%. Still, more drugs are getting higher price tags in 2025 ...
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania.The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder.[8]GSK announced plans to spin off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division".